MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Mild Parkinsonian signs and TIA/stroke

    J.L. Adams, N. Dahodwala (Rochester, NY, USA)

    Objective: We aimed to determine if MPS increases TIA/stroke risk. Background: Mild Parkinsonian signs (MPS) are a syndrome of mild basal ganglia dysfunction characterized by…
  • 2016 International Congress

    Autonomic failure and circadian rhythm of arterial blood pressure in IDIOPATHIC REM behaviour disorders and Parkinson’s disease

    R. Zangaglia, E. Guaschino, N. Ghiotto, B. Minafra, M. Terzaghi, G. Capone, A. Spiritelli, D. Bosone, C. Pacchetti (Pavia, Italy)

    Objective: Aim of our study is to correlate the autonomic nervous system failure and circadian rhythm of arterial blood pressure in idiopathic REM behaviour disorders…
  • 2016 International Congress

    Unawareness of causes of sudden deterioration in Parkinson’s patients in movement disorder clinic

    V. Paramanandam, D.A. Olszewska, C. Fearon, B. Magennis, T. Lynch (Dublin, Ireland)

    Objective: To evaluate patient's awareness of reversible causes of worsening of Parkinson's disease (PD)1, their impact on symptoms and the role of abdominal x-ray (PFA)…
  • 2016 International Congress

    Monitoring oxidative stress and progression to cell death: From secretome to blood diagnosis

    S.I. Anjo, V.M. Mendes, M. Grãos, B. MAnadas (Cantanhede, Portugal)

    Objective: To achieve a comprehensive method able to distinguish the secretome changes caused by oxidative stress regulation or induction of cell death, and thus be…
  • 2016 International Congress

    Progressive supranuclear palsy as a manifestation of the second stage of CADASIL syndrome

    B. Muinjonov, E. Giyazitdinova, G. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: To describe progressive supranuclear palsy (PSP) as a clinical manifestation of second stage CADASIL syndrome. Background: Recent data suggests that CADASIL syndrome in rare…
  • 2016 International Congress

    MRI-supported diagnosis of multiple system atrophy: Implications for clinical trials

    F. Krismer, G.K. Wenning, S. Bajaj, M. Schocke, C. Scherfler, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective: To assess whether MSA-specific MRI changes predict a more rapid clinical decline in a cohort of patients with a clinical diagnosis of MSA. Background:…
  • 2016 International Congress

    Clusterin CSF levels in differential diagnosis of neurodegenerative disorders

    M. Frolova, H. Prikrylova Vranova, E. Henykova, J. Mares, M. Kaiserova, K. Mensikova, M. Vastik, P. Hlustik, J. Zapletalova, M. Strnad, D. Stejskal, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To find a specific in vivo marker to improve a differential diagnosis between Parkinson´s disease and atypical Parkinsonian syndromes, especially early in the course…
  • 2016 International Congress

    Cognitive functioning in Parkinson’s disease and Parkinson plus syndrome

    S. Mina, V.K. Verma, K.S. Anand (New Delhi, India)

    Objective: Our study aimed to investigate and compare the cognitive functioning in PD and PPS. Background: Parkinson[s] disease (PD) is now known to be associated…
  • 2016 International Congress

    Clinicopathological characteristics of co-existant Parkinson’s disease and corticobasal degeneration: A case study

    K. Andruska, C. Kilbane, E. Plowey, K. Poston (Stanford, CA, USA)

    Objective: Parkinsonism is characterized by bradykinesia, rigidity, rest tremor, and postural instability. The most common cause of parkinsonism is Parkinson's disease (PD) and, rarely, Parkinson-plus…
  • 2016 International Congress

    The relationship between the cognitive phenotype and 5-HT2A receptor in PD with visual hallucinations

    S.S. Cho, A.P. Strafella, S. Duff-Canning, M. Zurowski, A.C. Vijverman, V. Bruno, C. de Aquino, M. Criaud, P.M. Rusjan, S. Houle, S.H. Fox (Toronto, ON, Canada)

    Objective: The aim of this study was to investigate the relationship between cognitive phenotype and 5-HT2A receptor availability in PD patients with visual hallucinations (VH).…
  • « Previous Page
  • 1
  • …
  • 103
  • 104
  • 105
  • 106
  • 107
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Common mistakes in the MoCA test in patients with Parkinson’s Disease in Kyrgyzstan
  • Clinical Associations of Hand Deformities in Parkinson´s Disease
  • #24970 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley